Operator of a stockbroking platform designed to provide financial investing services.
Operator of a stockbroking platform designed to provide financial investing services.
Brokerage📍 Mumbai, IndiaFounded 2009
Current Valuation
$3.4B
as of 2021-Q4
UNICORN
QL Price
$3.4B
0% vs last round
QuantLogix's current estimate for Upstox, published 2026-09-27 — in line with the last disclosed round of $3.4B (2021-Q4).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$3.4B
2021-Q4
weight 0.04
How this price has held up
No round has priced for Upstox since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Upstox, 2026-09-27 (8a988a8633c17c27).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Upstox going public?
No. Upstox is private and has not filed to go public. There is no S-1 on file.
What is Upstox's valuation in 2026?
Upstox is valued at $3.4B as of 2021-Q4, set by its Series C ($24.84M, Nov 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Upstox filed an S-1?
No public S-1 is on file for Upstox.
How much has Upstox raised?
Upstox has raised $53.75M in total, most recently a Series C of $24.84M in Nov 2021.
Is Upstox publicly traded — can you buy Upstox stock?
No. Upstox is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Upstox on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2009
HQ
Mumbai, India
Employees
600
Total Raised
$53.75M
Last Round
Series C — $24.84M (Nov 2021)
IPO Status
private
Fundraising Status
Series C · $24.84M · 4y 10mo ago
privateTotal raised $53.75M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$24.84M
Nov 2021
—
$3.4B
Talent Signal
Hiring trend
▲ Hiring uptrend
+157% vs 2026-08
Open roles
18
via careers page
Product-build share
44%
engineering, research, product, design
Trajectory
expanding
balanced build + GTM — 44% builders vs 56% go-to-market/G&A — scaling both sides.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Sun PharmaceuticalTorrent PharmaceuticalsTrust & SecurityProduct Manager II-(Growth)Product Manager II - Lending/MTFApplication Security Engineer-1
Counted from Upstox's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Financial ServicesFinTechTrading Platform
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.